肺癌细胞学样本的ALK与ROS1检测:现状与展望
本文综述了在肺癌细胞学标本中进行ALK与ROS1融合检测的研究进展。FISH和免疫细胞化学(ICC)可用于细胞学样本,但两者结果并不总是一致,且ICC性能取决于抗体克隆、信号检测系统和评分系统。新兴的二代测序和数字色码条码技术可单次分析ALK、ROS1和EGFR改变,未来可能取代FISH和ICC。
要点
- 细胞学采样是晚期肺癌诊断的主要方式,可用于EGFR突变及ALK、ROS1重排检测。
- FISH和ICC可应用于细胞学样本,但结果不总一致,ICC性能依赖抗体克隆和评分系统。
- 二代测序和数字色码条码技术可单次分析ALK、ROS1和EGFR,未来可能取代FISH和ICC。
核心结论
- FISH和ICC可应用于细胞学样本检测ALK和ROS1,但需注意结果不总一致且ICC性能受多种因素影响。
- 新兴的二代测序和数字色码条码技术可单次分析ALK、ROS1和EGFR改变,未来可能取代FISH和ICC。
研究设计与样本
- 本文为综述,回顾了在细胞学标本上检测ALK和ROS1的研究。
主要发现
- FISH和ICC结果并不总是保持一致。
- ICC的性能很大程度上取决于抗体克隆、信号检测系统和评分系统。
- 二代测序和数字色码条码技术可同时评估ALK、ROS1和EGFR改变。
关键数值与推荐
- FISH和ICC可用于细胞学样本,但需知晓结果不总一致。
- ICC性能依赖抗体克隆、信号检测系统和评分系统。
- 二代测序和数字色码条码技术可单次分析ALK、ROS1和EGFR改变。
临床怎么用
- 细胞病理医生应知晓FISH和ICC结果不总一致,ICC判读需考虑抗体克隆和评分系统。
- 关注新兴二代测序和数字色码条码技术在细胞学样本中同时检测ALK、ROS1和EGFR的潜力。
局限性
- 新兴技术在临床细胞学实践中的应用尚未完全确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cytologic sampling is the mainstay of diagnosing advanced lung cancer. Moreover, to select patients for personalized first-line or second-line treatment, epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) rearrangements are tested on cytologic preparations. Commercially available fluorescence in situ hybridization (FISH) and immunocytochemistry (ICC) assays have primarily been used for the identification of cells harboring ALK or ROS1 gene fusions on histologic rather than cytologic preparations. However, it is now recognized that FISH and ICC also can be applied on cytologic samples provided the cytopathologist is aware that FISH and ICC results are not always concordant and that the performance of ICC largely depends on antibody clones, signal detection systems, and scoring systems. Notably, the routine clinical use of FISH and ICC may be replaced by emerging next-generation sequencing and digital, color-coded barcode technologies, which have the advantage of simultaneously evaluating ALK, ROS1, and EGFR alterations in a single analysis. Although their use in clinical cytologic practice remains to be fully established, it is conceivable that this technology will replace both FISH and ICC analyses in future diagnostic algorithms. Here, the authors review studies devoted to testing ALK and ROS1 on cytology specimens in an attempt to provide an update for the cytopathologist regarding current and evolving practice. Cancer Cytopathol 2017;125:817-30. © 2017 American Cancer Society.
引用
- Pisapia P, Lozano MD, Vigliar E, et al. ALK and ROS1 testing on lung cancer cytologic samples: Perspectives. Cancer Cytopathol. 2017. PMID: 28743163. doi:10.1002/cncy.21899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。